Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26

Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other labor...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 5; no. 5; p. e10817
Main Authors Fletcher, Mary A., Zeng, Xiao R., Maher, Kevin, Levis, Silvina, Hurwitz, Barry, Antoni, Michael, Broderick, Gordon, Klimas, Nancy G.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 25.05.2010
Public Library of Science (PLoS)
Subjects
Abnormalities
Adolescent
Adult
Age
Alcohol
Analysis
Antigens
Assaying
Bioassays
Bioindicators
Biological markers
Biomarkers
Biomarkers - blood
Cadmium
Case-Control Studies
Cell activation
Chromium radioisotopes
Chronic fatigue syndrome
Chronic illnesses
Cytokines
Cytometry
Cytotoxicity
Cytotoxicity, Immunologic
Diabetes
Diagnostic systems
Dipeptidyl Peptidase 4 - blood
Dipeptidyl-peptidase IV
Drug abuse
Enzyme-linked immunosorbent assay
Fatigue
Fatigue Syndrome, Chronic - blood
Fatigue Syndrome, Chronic - diagnosis
Fatigue Syndrome, Chronic - enzymology
Fatigue Syndrome, Chronic - immunology
Female
Flow cytometry
Health aspects
Hepatitis
Humans
Immunoglobulins
Immunology
Immunology/Immunity to Infections
Immunology/Innate Immunity
Immunology/Leukocyte Activation
Infectious Diseases/Viral Infections
Inflammation
Insulin resistance
Killer cells
Killer Cells, Natural - immunology
Laboratory tests
Lymphocytes
Lymphocytes T
Male
Measurement methods
Medical research
Medicine
Middle Aged
Natural killer cells
Peptidase
Prognosis
Rheumatoid arthritis
ROC Curve
Studies
Systematic review
T cells
Toxicity
Women's Health
Young Adult
Florida
United States > US
Online AccessGet full text

Cover

Abstract Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and (51)Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
AbstractList Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and .sup.51 Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Methods/Results Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and .sup.51 Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. Conclusions By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and 51Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and (51)Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Methods/Results Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and 51 Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. Conclusions By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS.BACKGROUNDChronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS.Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and (51)Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC.METHODS/RESULTSSubjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and (51)Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC.By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.CONCLUSIONSBy ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS.Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and (51)Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC.By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Methods/Results Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and 51Cr release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. Conclusions By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.
Audience Academic
Author Hurwitz, Barry
Antoni, Michael
Fletcher, Mary A.
Broderick, Gordon
Levis, Silvina
Maher, Kevin
Zeng, Xiao R.
Klimas, Nancy G.
AuthorAffiliation New York University, United States of America
3 Department of Psychology, University of Miami, Coral Gables, Florida, United States of America
2 Miami Veterans Health Care Center, Miami, Florida, United States of America
1 Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America
4 Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
AuthorAffiliation_xml – name: 4 Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
– name: 1 Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America
– name: 2 Miami Veterans Health Care Center, Miami, Florida, United States of America
– name: New York University, United States of America
– name: 3 Department of Psychology, University of Miami, Coral Gables, Florida, United States of America
Author_xml – sequence: 1
  givenname: Mary A.
  surname: Fletcher
  fullname: Fletcher, Mary A.
– sequence: 2
  givenname: Xiao R.
  surname: Zeng
  fullname: Zeng, Xiao R.
– sequence: 3
  givenname: Kevin
  surname: Maher
  fullname: Maher, Kevin
– sequence: 4
  givenname: Silvina
  surname: Levis
  fullname: Levis, Silvina
– sequence: 5
  givenname: Barry
  surname: Hurwitz
  fullname: Hurwitz, Barry
– sequence: 6
  givenname: Michael
  surname: Antoni
  fullname: Antoni, Michael
– sequence: 7
  givenname: Gordon
  surname: Broderick
  fullname: Broderick, Gordon
– sequence: 8
  givenname: Nancy G.
  surname: Klimas
  fullname: Klimas, Nancy G.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20520837$$D View this record in MEDLINE/PubMed
BookMark eNqNk9tuEzEQhlcIRA_wBggsIYG4SOrTete9QCppCxEVRRR6azk-JC6OHezdir49TppWTVWhai_WGn_ze_x7Zqd6GmIwVfUKwSEiDdq7iH0K0g8XJTyEEMEWNU-qbcQJHjAMydM7661qJ-cLCGvSMva82sKwxrAlzXaVP7k4l-m3SRm4AEazFINT4Fh2btobcHYVdIpzsw-OLqXvSzQGEC34Jrs-SQ--Ou9NAiPjPTjug1rty6DBoVuYRef0lQffVwuZDRif740OMXtRPbPSZ_Ny_d-tfh0f_Rx9GZycfh6PDk4Gqml5N6BkUlPTakiZRnRSt0or21iDVY0bTi2xZNIizpE0hmmsjLSUt5Zz3upGaUp2qzfXugsfs1j7lQXCHFOGGW8KMb4mdJQXYpFcseJKROnEKhDTVMjUOeWNYNTURCOF24ZSZFkpgNqacogJ0jXVRevj-rR-MjdamdAVhzZEN3eCm4lpvBRFkUGyLOb9WiDFP73JnZi7rIqzMpjYZ9FQRiAj9BEkIYgSSFEh394jH7ZhTU1luakLNpYC1VJTHJTjWk4IXlLDB6jyaTN3qnShdSW-kfBhI6EwnfnbTWWfsxif_Xg8e3q-yb67w86M9N0sR98vmy9vgq_vPsntW9y0fwHoNaBSzDkZe4sgKJZTdmOXWE6ZWE9ZSdu_l6Zct5qN4ojz_0_-B9cOK_o
CitedBy_id crossref_primary_10_1016_j_jpsychores_2012_01_010
crossref_primary_10_5319_wjo_v3_i3_42
crossref_primary_10_1080_21641846_2016_1160598
crossref_primary_10_3389_fimmu_2017_00723
crossref_primary_10_1016_j_mayocp_2021_07_004
crossref_primary_10_7326_M15_0357
crossref_primary_10_1111_cei_12749
crossref_primary_10_1093_intimm_dxt068
crossref_primary_10_1016_j_pnpbp_2020_110230
crossref_primary_10_1186_1741_7015_11_64
crossref_primary_10_1038_srep34990
crossref_primary_10_3389_fimmu_2019_00796
crossref_primary_10_3389_fimmu_2024_1352744
crossref_primary_10_1155_2019_1684198
crossref_primary_10_3389_fimmu_2018_01028
crossref_primary_10_3390_ijms241511937
crossref_primary_10_1016_j_bbi_2019_11_015
crossref_primary_10_3389_fimmu_2024_1386607
crossref_primary_10_1186_s13643_019_1202_6
crossref_primary_10_1186_s12967_021_02974_4
crossref_primary_10_1002_pds_3503
crossref_primary_10_1186_s12887_016_0596_8
crossref_primary_10_1186_1477_7525_12_64
crossref_primary_10_1038_s41598_021_86425_6
crossref_primary_10_1155_2016_2497348
crossref_primary_10_1186_1479_5876_10_88
crossref_primary_10_1371_journal_pone_0085387
crossref_primary_10_1016_j_jad_2012_04_004
crossref_primary_10_1186_s12967_017_1161_4
crossref_primary_10_1371_journal_pone_0272703
crossref_primary_10_1002_cncr_27612
crossref_primary_10_1016_j_clinthera_2019_01_011
crossref_primary_10_1016_j_mehy_2012_07_034
crossref_primary_10_1073_pnas_2415119121
crossref_primary_10_1097_JOM_0b013e318229a938
crossref_primary_10_1097_MAO_0b013e3182635417
crossref_primary_10_1186_s12967_023_03958_2
crossref_primary_10_1016_j_lfs_2021_119819
crossref_primary_10_3390_diagnostics9030080
crossref_primary_10_1080_1744666X_2022_2116002
crossref_primary_10_3390_ijerph182211879
crossref_primary_10_1007_s11011_012_9324_8
crossref_primary_10_1016_j_neucli_2017_02_002
crossref_primary_10_1371_journal_pone_0081155
crossref_primary_10_1186_1479_5876_11_68
crossref_primary_10_1186_s12916_023_02893_9
crossref_primary_10_3389_fimmu_2021_628741
crossref_primary_10_7556_jaoa_2019_081
crossref_primary_10_1186_s40659_016_0087_2
crossref_primary_10_1042_BST20170503
crossref_primary_10_1186_s40360_018_0203_8
crossref_primary_10_3390_ijms24032010
crossref_primary_10_3390_jcm5060055
crossref_primary_10_1186_s40779_023_00505_4
crossref_primary_10_1007_s11011_019_0388_6
crossref_primary_10_1371_journal_pone_0143970
crossref_primary_10_4161_sysb_28948
crossref_primary_10_1007_s00018_022_04380_5
crossref_primary_10_1080_21641846_2014_906066
crossref_primary_10_1111_j_1365_2796_2011_02499_x
crossref_primary_10_1007_s13317_013_0051_x
crossref_primary_10_1186_s12865_016_0142_3
crossref_primary_10_1016_j_bbi_2012_06_006
crossref_primary_10_1186_1479_5876_9_81
crossref_primary_10_1186_s12967_025_06146_6
crossref_primary_10_1186_1471_2334_12_258
crossref_primary_10_1186_s12967_016_1010_x
crossref_primary_10_3389_fimmu_2024_1440643
crossref_primary_10_3389_fimmu_2019_02545
crossref_primary_10_1016_j_heliyon_2021_e07665
crossref_primary_10_1111_jcmm_15260
crossref_primary_10_3389_fimmu_2021_644548
crossref_primary_10_1371_journal_pone_0150904
crossref_primary_10_1111_j_1365_2796_2011_02428_x
crossref_primary_10_1016_j_fob_2013_12_001
crossref_primary_10_1172_jci_insight_158193
crossref_primary_10_1016_j_autrev_2018_01_009
crossref_primary_10_1016_j_jad_2012_03_037
crossref_primary_10_1111_j_1365_2796_2011_02405_x
crossref_primary_10_3390_jcm10112420
crossref_primary_10_1186_1741_7015_11_205
crossref_primary_10_1186_1743_422X_10_332
Cites_doi 10.1002/eji.200323469
10.1186/1744-9081-4-44
10.1177/13591053030084005
10.1016/j.bbi.2004.09.001
10.1016/j.jpsychores.2006.03.001
10.1016/j.virol.2005.10.034
10.1001/jama.298.2.194
10.1111/j.1365-2249.2005.02935.x
10.1046/j.1440-1819.2003.01132.x
10.1016/0140-6736(91)91440-6
10.1016/j.bbi.2008.11.005
10.1080/07399330600803766
10.1016/S0022-3956(96)00048-9
10.1371/journal.pone.0008519
10.1016/S0022-3999(02)00515-9
10.1126/science.1179052
10.1128/JCM.28.6.1403-1410.1990
10.1111/j.1440-1746.2006.04677.x
10.1016/j.ygeno.2008.08.008
10.2147/VHRM.S1707
10.7326/0003-4819-118-4-199302150-00001
10.4049/jimmunol.139.10.3306
10.1159/000067176
10.1016/S0002-9440(10)62266-3
10.1186/1476-5918-7-6
10.1186/1478-7547-2-4
10.1186/1472-6963-3-25
10.1111/j.1365-2567.2008.02899.x
10.1093/clinids/18.Supplement_1.S136
10.1080/09638280701500109
10.1001/archinte.163.13.1530
10.1001/archinte.159.18.2129
10.7326/0003-4819-121-12-199412150-00009
10.1016/j.cair.2005.10.001
10.2165/00003495-200262170-00003
10.1016/S1386-6532(06)70009-9
10.1073/pnas.88.7.2922
ContentType Journal Article
Copyright COPYRIGHT 2010 Public Library of Science
2010 Fletcher et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Fletcher et al. 2010
Copyright_xml – notice: COPYRIGHT 2010 Public Library of Science
– notice: 2010 Fletcher et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Fletcher et al. 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0010817
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale in Context Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Materials Science & Engineering
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

AIDS and Cancer Research Abstracts
MEDLINE



MEDLINE - Academic


Agricultural Science Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Biomarkers in CFS
EISSN 1932-6203
ExternalDocumentID 1292462697
oai_doaj_org_article_64e53d1c287441f694f4f5490231d54d
PMC2876037
2898409371
A473893327
20520837
10_1371_journal_pone_0010817
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Florida
United States--US
GeographicLocations_xml – name: Florida
– name: United States--US
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL65668
– fundername: NIAID NIH HHS
  grantid: R01 AI065723
– fundername: NIAAA NIH HHS
  grantid: R21AA016635
– fundername: NHLBI NIH HHS
  grantid: R01 HL065668
– fundername: NIAMS NIH HHS
  grantid: R01 AR48932-01A1
– fundername: NINDS NIH HHS
  grantid: R01 NS055672
– fundername: NIAID NIH HHS
  grantid: R01AI065723
– fundername: NIAMS NIH HHS
  grantid: R01 AR048932
– fundername: NIAID NIH HHS
  grantid: U01 AI459940
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
BBORY
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c789t-43b54e8d046d14b58cdcf7fe2c52794f3f3b81991aee6d2ceaf498f9998d7cd43
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Apr 03 16:01:23 EDT 2022
Wed Aug 27 01:31:18 EDT 2025
Thu Aug 21 14:06:24 EDT 2025
Fri Jul 11 08:02:27 EDT 2025
Thu Jul 10 23:08:44 EDT 2025
Fri Jul 25 11:59:56 EDT 2025
Tue Jun 17 21:21:16 EDT 2025
Tue Jun 10 20:51:11 EDT 2025
Fri Jun 27 03:34:18 EDT 2025
Fri Jun 27 05:09:17 EDT 2025
Thu May 22 20:54:41 EDT 2025
Wed Feb 19 02:23:09 EST 2025
Tue Jul 01 03:53:56 EDT 2025
Thu Apr 24 22:59:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c789t-43b54e8d046d14b58cdcf7fe2c52794f3f3b81991aee6d2ceaf498f9998d7cd43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: MAAF KM NGK. Performed the experiments: XRZ KM. Analyzed the data: MAAF GJB. Contributed reagents/materials/analysis tools: SL BH MA. Wrote the paper: MAAF NGK. Critically reviewed paper: BH, MA, GJB.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0010817
PMID 20520837
PQID 1292462697
PQPubID 1436336
PageCount e10817
ParticipantIDs plos_journals_1292462697
doaj_primary_oai_doaj_org_article_64e53d1c287441f694f4f5490231d54d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2876037
proquest_miscellaneous_746306347
proquest_miscellaneous_733143041
proquest_journals_1292462697
gale_infotracmisc_A473893327
gale_infotracacademiconefile_A473893327
gale_incontextgauss_ISR_A473893327
gale_incontextgauss_IOV_A473893327
gale_healthsolutions_A473893327
pubmed_primary_20520837
crossref_primary_10_1371_journal_pone_0010817
crossref_citationtrail_10_1371_journal_pone_0010817
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-05-25
PublicationDateYYYYMMDD 2010-05-25
PublicationDate_xml – month: 05
  year: 2010
  text: 2010-05-25
  day: 25
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2010
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References KJ Maher (ref20) 2005; 142
MH Zweig (ref26) 1993; 39
E DeFreitas (ref31) 1991; 88
B Evengård (ref27) 2002; 62
PH Levine (ref11) 1992; 52
CC Ibegbu (ref38) 2009; 126
R Glaser (ref29) 2005; 19
NA Thornberry (ref41) 2009; 223
D Ledina (ref30) 2007; 13
R Glaser (ref36) 2006; 346
B Richter (ref42) 2008; 4
LA Jason (ref10) 2006; 27
K Fukuda (ref1) 1994; 121
K Maher (ref25) 2006; 5
AL Landay (ref16) 1991; 338
MJ Holmes (ref33) 1997; 31
AL Aspler (ref22) 2008; 4
WC Reeves (ref2) 2003; 3(1)
KJ Reynolds (ref6) 2004; 2(1)
TR Gerrity (ref8) 2003; 10
O Erlwein (ref35) 2010; 5(1)
SS Yang (ref37) 2006; 21
A Straburzynska-Lupa (ref45) 2010; 2010 28(1)
AS Khan (ref32) 1993; 118(4)
K Maher (ref17) 2003
HK Chandler (ref5) 2008; 30(16)
CL Raison (ref21) 2009; 23
VC Lombardi (ref34) 2009; 326
NG Klimas (ref14) 1990; 28
E Barker (ref15) 1994; 18
J Fuite (ref46) 2008; 92
B Evengård (ref12) 2003; 57
M Lyall (ref18) 2003; 55
MA Fletcher (ref24) 1987; 5
LA Jason (ref13) 2003; 8
RE Amori (ref43) 2007; 11;298
LA Jason (ref4) 1999; 159
AM Kogelnik (ref28) 2006; 37
S Yan (ref44) 2003; 33
C Muscat (ref40) 1994; 98(2)
SD Siegel (ref23) 2006; 60
N Busso (ref39) 2005; 166
M Caligiuri (ref19) 1987; 139
M Reyes (ref3) 2003; 163
LA Jason (ref7) 2008; 7
BE Hurwitz (ref9); 118(2)
References_xml – volume: 33
  start-page: 1519
  year: 2003
  ident: ref44
  article-title: Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.
  publication-title: Eur J Immunol.
  doi: 10.1002/eji.200323469
– volume: 4
  start-page: 44
  year: 2008
  ident: ref22
  article-title: Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.
  publication-title: Behav Brain Funct
  doi: 10.1186/1744-9081-4-44
– volume: 8
  start-page: 459
  year: 2003
  ident: ref13
  article-title: Comparing symptoms of chronic fatigue syndrome in a community-based versus tertiary care sample.
  publication-title: J Health Psychol
  doi: 10.1177/13591053030084005
– volume: 39
  start-page: 561
  year: 1993
  ident: ref26
  article-title: Receiver-Operating Characteristic (ROC) plots: A fundamental evaluation tool in Clin Med Clin Chem.
– volume: 19
  start-page: 91
  year: 2005
  ident: ref29
  article-title: Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer.
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2004.09.001
– volume: 60
  start-page: 559
  year: 2006
  ident: ref23
  article-title: Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup?
  publication-title: J Psychosom Res
  doi: 10.1016/j.jpsychores.2006.03.001
– volume: 346
  start-page: 205
  year: 2006
  ident: ref36
  article-title: EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease.
  publication-title: Virology
  doi: 10.1016/j.virol.2005.10.034
– volume: 11;298
  start-page: 194
  year: 2007
  ident: ref43
  article-title: Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
  publication-title: JAMA
  doi: 10.1001/jama.298.2.194
– volume: 142
  start-page: 505
  year: 2005
  ident: ref20
  article-title: Chronic fatigue syndrome is associated with diminished intracellular perforin.
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2005.02935.x
– volume: 57
  start-page: 361
  year: 2003
  ident: ref12
  article-title: : Differences between patients with chronic fatigue syndrome and with chronic fatigue at an infectious disease clinic in Stockholm, Sweden.
  publication-title: Psychiatry Clin Neurosci
  doi: 10.1046/j.1440-1819.2003.01132.x
– volume: 338
  start-page: 707
  year: 1991
  ident: ref16
  article-title: Chronic fatigue syndrome: clinical condition associated with immune activation.
  publication-title: Lancet
  doi: 10.1016/0140-6736(91)91440-6
– volume: 23
  start-page: 327
  year: 2009
  ident: ref21
  article-title: Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2008.11.005
– volume: 27
  start-page: 615
  year: 2006
  ident: ref10
  article-title: Causes of death among patients with chronic fatigue syndrome.
  publication-title: Health Care Women Int
  doi: 10.1080/07399330600803766
– volume: 31
  start-page: 115
  year: 1997
  ident: ref33
  article-title: Electron microscopic immunocytological profiles in chronic fatigue syndrome.
  publication-title: J Psychiatr Res
  doi: 10.1016/S0022-3956(96)00048-9
– volume: 5(1)
  start-page: e8519
  year: 2010
  ident: ref35
  article-title: Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008519
– volume: 55
  start-page: 79
  year: 2003
  ident: ref18
  article-title: A systematic review and critical evaluation of the immunology of chronic fatigue syndrome.
  publication-title: J Psychosom Res
  doi: 10.1016/S0022-3999(02)00515-9
– volume: 326
  start-page: 585
  year: 2009
  ident: ref34
  article-title: Detection of infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
  publication-title: Science
  doi: 10.1126/science.1179052
– volume: 223
  start-page: 479
  year: 2009
  ident: ref41
  article-title: Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) Best Pract Res Clin EndocrinolMetab.
– volume: 13
  start-page: CS88
  year: 2007
  ident: ref30
  article-title: Chronic fatigue syndrome after Q fever.
  publication-title: Med Sci Monit
– volume: 98(2)
  start-page: 252
  year: 1994
  ident: ref40
  article-title: Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients.
  publication-title: Clin Exp Immunol
– volume: 28
  start-page: 1403
  year: 1990
  ident: ref14
  article-title: Immunologic abnormalities of chronic fatigue syndrome.
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.28.6.1403-1410.1990
– volume: 21
  start-page: 1789
  year: 2006
  ident: ref37
  article-title: Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2006.04677.x
– volume: 92
  start-page: 393
  year: 2008
  ident: ref46
  article-title: Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2008.08.008
– volume: 4
  start-page: 753
  year: 2008
  ident: ref42
  article-title: Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/VHRM.S1707
– volume: 118(4)
  start-page: 241
  year: 1993
  ident: ref32
  article-title: Folks TM, Schonberger LB. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-118-4-199302150-00001
– volume: 139
  start-page: 3306
  year: 1987
  ident: ref19
  article-title: Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
  publication-title: J Immunol
  doi: 10.4049/jimmunol.139.10.3306
– volume: 5
  start-page: 69
  year: 1987
  ident: ref24
  article-title: Use of whole blood methods in assessment of immune parameters in immunodeficiency states.
  publication-title: Diag Clin Immunol
– volume: 10
  start-page: 134
  year: 2003
  ident: ref8
  article-title: Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness?
  publication-title: Neuroimmunomodulation
  doi: 10.1159/000067176
– volume: 166
  start-page: 433
  year: 2005
  ident: ref39
  article-title: Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62266-3
– volume: 7
  start-page: 6
  year: 2008
  ident: ref7
  article-title: The economic impact of ME/CFS: Individual and societal costs.
  publication-title: Dyn Med
  doi: 10.1186/1476-5918-7-6
– volume: 52
  start-page: 5516s
  issue: 19
  year: 1992
  ident: ref11
  article-title: Does chronic fatigue syndrome predispose to non-Hodgkin's lymphoma?
  publication-title: Cancer Res
– volume: 2(1)
  start-page: 4
  year: 2004
  ident: ref6
  article-title: The economic impact of chronic fatigue syndrome.
  publication-title: Cost Eff Resour Alloc
  doi: 10.1186/1478-7547-2-4
– volume: 2010 28(1)
  start-page: 19
  year: 2010
  ident: ref45
  article-title: Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis.
  publication-title: Clin Exp Rheumatol
– volume: 3(1)
  start-page: 25
  year: 2003
  ident: ref2
  article-title: Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-3-25
– volume: 126
  start-page: 346
  year: 2009
  ident: ref38
  article-title: Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2008.02899.x
– volume: 18
  start-page: S136
  year: 1994
  ident: ref15
  article-title: Immunologic abnormalities associated with chronic fatigue syndrome.
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/18.Supplement_1.S136
– volume: 30(16)
  start-page: 1185
  year: 2008
  ident: ref5
  article-title: Medically unexplained illness in short- and long-term disability applicants: prevalence and cost of salary reimbursement.
  publication-title: Disabil Rehabil
  doi: 10.1080/09638280701500109
– start-page: 124
  year: 2003
  ident: ref17
  article-title: Immunology.
– volume: 118(2)
  start-page: 125
  ident: ref9
  article-title: Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function.
  publication-title: Clin Sci (Lond)
– volume: 163
  start-page: 1530
  year: 2003
  ident: ref3
  article-title: Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas.
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.13.1530
– volume: 159
  start-page: 2129
  year: 1999
  ident: ref4
  article-title: A community-based study of chronic fatigue syndrome.
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.159.18.2129
– volume: 121
  start-page: 953
  year: 1994
  ident: ref1
  article-title: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-121-12-199412150-00009
– volume: 5
  start-page: 353
  year: 2006
  ident: ref25
  article-title: Quantitative flow cytometry in the clinical laboratory, Clin.
  publication-title: Appl Immunol Rev
  doi: 10.1016/j.cair.2005.10.001
– volume: 62
  start-page: 2433
  year: 2002
  ident: ref27
  article-title: Chronic fatigue syndrome: Probable pathogenesis and possible treatments.
  publication-title: Drugs
  doi: 10.2165/00003495-200262170-00003
– volume: 37:
  start-page: S33
  year: 2006
  ident: ref28
  article-title: Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(06)70009-9
– volume: 88
  start-page: 2922
  year: 1991
  ident: ref31
  article-title: Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome.
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.88.7.2922
SSID ssj0053866
Score 2.3269522
Snippet Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of...
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated...
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e10817
SubjectTerms Abnormalities
Adolescent
Adult
Age
Alcohol
Analysis
Antigens
Assaying
Bioassays
Bioindicators
Biological markers
Biomarkers
Biomarkers - blood
Cadmium
Case-Control Studies
Cell activation
Chromium radioisotopes
Chronic fatigue syndrome
Chronic illnesses
Cytokines
Cytometry
Cytotoxicity
Cytotoxicity, Immunologic
Diabetes
Diagnostic systems
Dipeptidyl Peptidase 4 - blood
Dipeptidyl-peptidase IV
Drug abuse
Enzyme-linked immunosorbent assay
Fatigue
Fatigue Syndrome, Chronic - blood
Fatigue Syndrome, Chronic - diagnosis
Fatigue Syndrome, Chronic - enzymology
Fatigue Syndrome, Chronic - immunology
Female
Flow cytometry
Health aspects
Hepatitis
Humans
Immunoglobulins
Immunology
Immunology/Immunity to Infections
Immunology/Innate Immunity
Immunology/Leukocyte Activation
Infectious Diseases/Viral Infections
Inflammation
Insulin resistance
Killer cells
Killer Cells, Natural - immunology
Laboratory tests
Lymphocytes
Lymphocytes T
Male
Measurement methods
Medical research
Medicine
Middle Aged
Natural killer cells
Peptidase
Prognosis
Rheumatoid arthritis
ROC Curve
Studies
Systematic review
T cells
Toxicity
Women's Health
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnLggyquBAiuEBBxM492x1-HWFqqWA0hAq95W9j7aiGBHdXLg3zOzXpsaVZQDtygzfmTek539lrGXmZ-ZVEmBjuQFNihzl1TIm3ib5aBKo8CGaYtP-dEJfDzLzq4c9UUzYR08cCe43RxcJm1qAk576vM5ePDY1BBumc3AUvTFnNc3U10MRi_O87hRTqp0N-rl7aqpHa09YB5Uo0QU8PqHqDxZLZv2upLzz8nJK6no8C67E2tIvte9-xa75ep7bCt6actfRyjpN_dZu79oftAAzmXLFzU3HRIu96iO843jPVzBO_4b9Js3nge0T3zC97BRkNOf-5wSYKCXteV2saJpGPtzybsPmAv58enuwXuRP2Anhx--HRwl8ZiFxKhivk5AVhm4wmKnbFOossJY45V3wmQCvdVLL6uCJqRK53IrjCs9zAuPlWVhlbEgH7JJjYLdZnyG3VzqfCWF81CAKSArUnBoDTNa3pVTJnuZaxMxyOkojKUOC2sKe5FOhJo0paOmpiwZrlp1GBw38O-TOgdeQtAOX6Bd6WhX-ia7mrLnZAy62446xAG9B4pqPCnwMS8CB6Fo1DSmc15u2lYffz79B6avX0ZMryKTb1AcpoxbI_A3ETrXiHNnxImxwIzI22S6vVRajdWcAOxZ53Rlb87Xk_lAppvS6F3tmk2r6VBPkDNI_8ICOXaeEvAujzr_GGQvaM6qkEhRI88ZKWdMqRcXAeYcNZPPpHr8P7T5hN3uxz5EtsMm68uNe4rV5Lp6FgLHLxRBchA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxMbHCgMshAQ8hDa2E7u8oK1b2UAMxNi0tyjxR6lUktK0D_z33LlOIGgavFW9S9rc-b7i8-8IeZ64oY4lZ2BIjkGBMrJRAbyRM0kqZK6lML7b4iQ9OhPvL5KL8MKtDm2VjU_0jtpUGt-RDyAuMQHZ90i-XfyIcGoU7q6GERrXyY0YIg22dKnJu8YTgy2naTgux2U8CNp5vahKizsQEA1lJxx51P7WN_cW86q-LPH8u3_yj4A0uUNuh0yS7m1Uv0Wu2XKb3PwY9sq3yVYw25q-DNjSr-6Sen9WfceOnGVNZyUN0Lh0AvqZri09DfgFb-hhiwJOK0dPcg_PQT_4k4N0bOdzOoGI6Ol5aejBbIHtMebnnH72HyA40uPzwfiApffI2eTw6_goCnMXIi3VaBUJXiTCKgOls4lFkShttJPOMp0wMF_HHS8Utkzl1qaGaZs7MVIOUk1lpDaC3ye9EmS8Q-gQlBZbV3BmnVBCK5GoWFhYHkPc7-V9whvxZzqAkuNsjHnmd9okFCcbaWaotCworU-i9qrFBpTjH_z7qNmWFyG1_RfVcpoFC81SYRNuYu0HAsQuhQcVDqpnBMgziTB98hTXRbY5n9o6hmxPSEz6OIOfeeY5EFajxL6dab6u6-z40_l_MJ1-6TC9CEyuAnHoPJyVgGdCuK4O526HE5yD7pB3cBU3Uqmz32YEVzYr-3Iybcl4U-zFK221rjOc8in4UMRXsIgUSlEu4C4PNqbSyp5h45XiQJEdI-oop0spZ9887jloJh1y-fDqP_6I3Go6PFiyS3qr5do-hsRxVTzx3uEXhOps6w
  priority: 102
  providerName: ProQuest
Title Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26
URI https://www.ncbi.nlm.nih.gov/pubmed/20520837
https://www.proquest.com/docview/1292462697
https://www.proquest.com/docview/733143041
https://www.proquest.com/docview/746306347
https://pubmed.ncbi.nlm.nih.gov/PMC2876037
https://doaj.org/article/64e53d1c287441f694f4f5490231d54d
http://dx.doi.org/10.1371/journal.pone.0010817
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaxygWQgIeMpLYiVMkhNauZQNRpo1OfYtSf5RKJSlNK7H_njvXjQgqsJeo6p1d5c7nu6vPvyPkRWR8GQgWgiGZEBKUtvbGwOsZFcVcZFJwZastBvHZkH8cRaMdsunZ6gRYbk3tsJ_UcDE7_vnj5j0Y_DvbtUEEm0HH8yLXeLIAXk7skj3wTQJ7Gnzm1bkCWLc9vcSoxYtDn7nLdH-bpeasLKZ_tXM35rOi3BaW_lld-Zu76t8jd12cSU_WC2Of7Oj8Ptl3llzSVw5u-vUDUnamxXcs0lmUdJpTh5ZL-6CyyUrTKwdp8Jb2KmBwWhg6yCxiB_1kLxPSrp7NaB-cpKVnuaKn0zlWzKibGb2wH8Bf0vPrN93TMH5Ihv3e1-6Z51oxeFIk7aXH2TjiOlGQTauAj6NEKmmE0aGMQrBowwwbJ1hFlWkdq1DqzPB2YiD6TJSQirNHpJGDYA8I9SHjC7QZs1AbnnCZ8CgJuIYV4-MRMGsStpF5Kh1OObbLmKX28E1AvrIWYYqaSp2mmsSrRs3XOB3_4e-gOiteRNm2XxSLSeqMNo25jpgKpO0REJgYXpQbSKgRM09FXDXJM1wM6frKarVXpCdcYBzIQviZ55YDkTZyLOWZZKuyTM-_XN-C6eqyxvTSMZkCxCEzd30C3gkRvGqcRzVO2C9kjXyAS3cjlTKFiC_kkNe2ceRmOW8n04qMk2J5Xq6LVZli40_OfB78g4XHkJ0yDrM8XttHJfsQa7ESBhRRs5yacuqUfPrNQqGDZmKficNbC-cJubOp_wijI9JYLlb6KYSVy3GL7IqRgGfSDfDZ_9Aie53e4OKyZf-oadmd5Be0eXqY
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9NADD-NIQEviI2PDQY7IRDwENbcXXIpEkJbu7LSrSD2ob2F9D5GpZKUZRXaP8XfiH29BIKmwcveqtpJE9tnn3v2z4Q8i2xLhZIzWEiWQYLSNsEIeAOro1jITEmhXbXFMN45FB-Oo-MF8rPqhcGyysonOketC4X_kW9AXGICdt9t-W76PcCpUXi6Wo3QmJvFwJz_gJStfNvvgn6fM9bbPujsBH6qQKBk0j4LBB9FwiQaEkMdilGUKK2stIapiIFxWm75KMGCoMyYWDNlMivaiYWNVKKl0oLDfa-R64JDJMfO9N77yvOD74hj357HZbjhreH1tMgNnnhA9JWN8OemBNSxYHE6KcqLNrp_12v-EQB7d8htv3Olm3NTWyILJl8mN_b82fwyWfJuoqQvPZb1q7uk3BoX37AC6LSk45x6KF7aA3s4mRm67_ES3tDtGnWcFpYOMwcHQgeuU5F2zGRCexCBHT3LNe2Op1iOo88n9JP7AMGY9o82Ol0W3yOHV6KR-2QxBxmvENoCIwmNHXFmrEiESkSUhMKAObbwfJmvEl6JP1UeBB1ncUxSd7InIRmaSzNFpaVeaaskqK-azkFA_sG_hZqteRHC231RnJ6k3iOksTAR16FyAwhCG8OLCgvZOgLy6UjoVbKOdpHO-2FrR5RuCombTM7gZ546DoTxyLFO6CSblWXa_3j0H0z7nxtMLzyTLUAcKvO9GfBOCA_W4FxrcIIzUg3yClpxJZUy_b1s4crKsi8m05qMN8Xav9wUszLFqaKCt0R4CYuIIfXlAu7yYL5UatkzLPRKOFBkYxE1lNOk5OOvDmcdNBO3uHx4-YOvk5s7B3u76W5_OHhEblXVJSxaI4tnpzPzGDatZ6MnzlNQ8uWqXdMv30urJw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEC2PFgpdIRBwMIl3114HCaE2adQQKBV9qDfj7KNECnaIG6H-NX4dM5u1wagqXHqLsmPHnvdkZ78h5Flk2yqUnIEhWQYFSscEI6ANrI5iITMlhXbdFvvx3rF4fxqdLpGf1VkYbKusfKJz1LpQ-B95C-ISE5B9d2TL-raIg17_3fR7gBOkcKe1GqexUJGhufgB5Vv5dtADWT9nrL971N0L_ISBQMmkcx4IPoqESTQUiToUoyhRWllpDVMRA0W13PJRgs1BmTGxZspkVnQSC0lVoqXSgsN9b5CbkssEbSzp1u0l4Efi2B_V4zJsec14PS1yg7sfEIllIxS6iQF1XFieTorysqT3797NP4Jh_w657bNYur1Qu1WyZPI1svLR79OvkVXvMkr60uNav7pLyp1x8Q27gWYlHefUw_LSPujG2dzQQ4-d8Ibu1gjktLB0P3PQIHToTi3SrplMaB-isVvPck174ym25uiLCT1wHyAw08FJq9tj8T1yfC0SuU-Wc-DxOqFtUJjQ2BFnxopEqERESSgMqGYb95r5BuEV-1PlAdFxLsckdbt8EgqjBTdTFFrqhbZBgvqq6QIQ5B_0OyjZmhbhvN0Xxews9d4hjYWJuA6VG0YQ2hheVFio3BGcT0dCb5At1It0cTa2dkrptpCYcHIGP_PUUSCkR47GcZbNyzIdfDr5D6LDzw2iF57IFsAOlflzGvBOCBXWoNxsUIJjUo3lddTiiitl-tuE4cpKsy9fpvUy3hT7AHNTzMsUJ4wK3hbhFSQihjKYC7jLg4Wp1Lxn2PSVcFiRDSNqCKe5ko-_Osx1kEzc5vLh1Q--RVbAKaUfBvvDR-RW1WjCok2yfD6bm8eQv56PnjhHQcmX6_ZMvwBqG68o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biomarkers+in+Chronic+Fatigue+Syndrome%3A+Evaluation+of+Natural+Killer+Cell+Function+and+Dipeptidyl+Peptidase+IV%2FCD26&rft.jtitle=PloS+one&rft.au=Fletcher%2C+Mary+A&rft.au=Zeng%2C+Xiao+R&rft.au=Maher%2C+Kevin&rft.au=Levis%2C+Silvina&rft.date=2010-05-25&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=5&rft.issue=5&rft.spage=e10817&rft_id=info:doi/10.1371%2Fjournal.pone.0010817&rft.externalDocID=A473893327
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon